Angiotensin receptor and endothelin receptor antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
C09CA Angiotensin II receptor blockers (ARBs), plain
C09CA04 Irbesartan
D00523 Irbesartan (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Angiotensin II Receptor Antagonists
Irbesartan
D00523 Irbesartan (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D00523 Irbesartan (JP18/USP/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01495 Angiotensin II receptor antagonist
D00523 Irbesartan
DG03231 Antihypertensive
DG01495 Angiotensin II receptor antagonist
D00523 Irbesartan
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
D00523 Irbesartan
Drug classes [BR:br08332]
Cardiovascular agent
DG01495 Angiotensin II receptor antagonist
D00523 Irbesartan
DG03231 Antihypertensive
D00523 Irbesartan
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Angiotensin
AGTR1
D00523 Irbesartan (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00523 Irbesartan
D00523 Irbesartan tablets
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00523
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00523
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00523